MRI + iEEG for Epilepsy
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests MRI techniques and brain wave recordings to improve epilepsy surgery outcomes. Researchers aim to discover new, noninvasive methods to predict and map seizure spread. This could lead to more targeted treatments for epilepsy patients unresponsive to medication. Individuals with medication-resistant epilepsy planning to undergo brain recordings before surgery might be suitable for this trial. As an Early Phase 1 trial, this research focuses on understanding how these new techniques work in people, offering participants a chance to contribute to groundbreaking advancements in epilepsy treatment.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, since the trial is for patients with medication-refractory epilepsy, it might be assumed that you can continue your current epilepsy medications.
What prior data suggests that MRI and iEEG are safe for epilepsy patients?
A previous study demonstrated that 3T MRI is safe and effective for epilepsy, providing clearer images than lower-strength scanners. This clarity helps doctors better observe changes in the brain. Safety data for 3T MRI confirm its safe use in both clinical and research settings.
Research indicates that 7T MRI is also well-tolerated and offers even more detailed images, aiding in the understanding of epilepsy. Studies have examined its safety and found 7T MRI to be safe for patients of different ages.
Intracranial electroencephalography (iEEG) has been safely used in many patients. While there are some risks, such as a small chance of bleeding or temporary symptoms, long-lasting problems are rare. Overall, iEEG is considered safe for monitoring brain activity.
These findings suggest that the treatments in this study are generally safe. However, as with any medical procedure, some risks are involved. Participants should discuss any concerns with the trial team.12345Why are researchers excited about this trial?
Researchers are excited about using 3T and 7T Magnetic Resonance Imaging (MRI) alongside intracranial electroencephalography (iEEG) recordings for epilepsy because these techniques offer a much more detailed view of brain activity than current standard treatments like medication or surface EEG. Unlike typical imaging, 3T and 7T MRI provide high-resolution images, making it easier to pinpoint the exact areas of the brain involved in seizures. The addition of iEEG, which involves placing electrodes directly on the brain, offers real-time monitoring of electrical activity with greater accuracy. These advanced methods could lead to more precise surgical decisions and potentially improve outcomes for patients with drug-resistant epilepsy.
What evidence suggests that MRI and iEEG are effective for epilepsy?
Research has shown that a 3T MRI effectively identifies structural issues in epilepsy, providing clearer images and detecting more lesions than the standard 1.5T MRI. In this trial, participants will undergo either 3T or 7T MRI. The 7T MRI offers even higher detail, aiding in the detection of small abnormalities that might be missed, especially in cases where medication is ineffective. Additionally, intracranial electroencephalography (iEEG) recordings, which participants in this trial will also undergo, are crucial for predicting surgical success in epilepsy. They help locate the brain areas where seizures begin, guiding successful surgeries. Together, these tools aim to improve treatment and surgical outcomes for people with epilepsy.13678
Who Is on the Research Team?
Kathryn A Davis, MD, MSTR
Principal Investigator
University of Pennsylvania
Are You a Good Fit for This Trial?
This trial is for individuals with drug-resistant epilepsy who are scheduled to have intracranial EEG (IEEG) placement and are thought to have temporal lobe epilepsy. It's not suitable for those with non-diagnostic IEEG results, contraindications to MRI like metal implants or claustrophobia, pregnant individuals, or those who've had prior brain surgery.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-implant Imaging
Patients undergo diffusion tensor imaging (DTI) and resting-state functional MRI (rsfMRI) prior to stereotactic IEEG
IEEG Monitoring
Patients undergo stereotactic IEEG to map seizure onset and propagation
Follow-up
Participants are monitored for safety and effectiveness after IEEG monitoring and potential surgical intervention
What Are the Treatments Tested in This Trial?
Interventions
- 3T Magnetic Resonance Imaging
- 7T Magnetic Resonance Imaging
- Intracranial electroencephalography recordings
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Pennsylvania
Lead Sponsor
Medical University of South Carolina
Collaborator